Fenestrated Endografts as Treatment for Type I Endoleak: What is the Price of Success?

Both fenestrated and branched endografts are effective to treat patients after failure of their initial endograft due to significant type I endoleak. This situation is costly both because of the devices themselves, and also due to the several endovascular and surgical procedures required.

Prótesis fenestradas para tratar endoleak tipo 1 ¿cuál es el precio del éxito?

Failure of an endograft to treat an infrarenal abdominal aortic aneurysm due to the development of a type Ia endoleak exposes patients to pressurization of the sac, which may cause a rupture. Type I endoleaks must undoubtedly be treated—unlike type II endoleaks, around which controversy may arise.

The purpose of this study was to evaluate the results of fenestrated/branched grafts for the treatment of type Ia endoleaks.

Between 2010 and 2019, 85 consecutive patients who received a fenestrated/branched graft after failure of a conventional prosthesis were included. The primary endpoint was freedom from re-intervention and death related to the procedure.

In 30 cases (35%), the initial prosthesis was implanted in a hostile neck—either too short (<10mm) or angled (>60°). Less frequent reasons were poor placement of the initial prosthesis, sizing error, or stent migration. 

Type Ia endoleaks were observed 59 ± 25 months following implantation of the initial prosthesis. As a solution, 82 fenestrated grafts and 3 branched grafts were used. Overall technical success was 94%, with one persistent type Ia endoleak, and two unsuccessful stent graft implantations.

In-hospital mortality rate was 5%, and the most feared complication in this type of procedure—spinal cord ischemia—occurred in four patients.


Read also: SOLACI PERIPHERAL | Type Ib Endoleak Correction in Patient After Minimally Invasive Hybrid Treatment in Type A Aortic Disection.


At three years, the survival rate was 64% with an overall freedom from any re-intervention or aneurysm-related death of 40%. However, the secondary patency rate of the target visceral arteries was 96%.

Despite all efforts, six patients had to undergo conventional surgery.

Conclusion

Fenestrated/branched grafts are an effective treatment when conventional prostheses fail due to type 1A endoleak, although re-interventions and device costs can be high.

Original title: Prospective Multicentre Cohort Study of Fenestrated and Branched Endografts After Failed Endovascular Infrarenal Aortic Aneurysm Repair with Type Ia Endoleak.

Reference: Aurélien Hostalrich et al. Eur J Vasc Endovasc Surg. 2021 Aug 4;S1078-5884(21)00525-6. Online ahead of print. doi: 10.1016/j.ejvs.2021.06.019. 


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....

Chronic Thromboembolic Pulmonary Hypertension: Treatment Outcomes According to a Worldwide Registry

Chronic thromboembolic pulmonary hypertension (CTEPH) is a highly limiting condition that, despite its moderate incidence, significantly impacts patient prognosis and quality of life. The...

Contemporary Outcomes of Acute Limb Ischemia Endovascular Revascularization

Acute limb ischemia (ALI) is a vascular emergency with high mortality rate. It has been defined as a sudden occlusion of limb perfusion compromising...

TCT 2024 | SIRONA: Randomized Study Comparing Sirolimus-Coated vs Paclitaxel-Coated Balloon Angioplasty in Femoropopliteal Disease

This prospective, randomized, multicenter, investigator-initiated non-inferiority study compared the use of sirolimus-coated balloon (MagicTouch) vs paclitaxel-coated balloon in endovascular treatment.  The primary objective was to...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Long Term Results of the International Chimney Registry

The International Chimney Registry was an observational study aimed at assessing the use of chimney stenting during TAVR either to predict or treat coronary...

CANNULATE TAVR extended study: Impact of Commissural and Coronary Alignment in Coronary Cannulation Following TAVR with Evolut Fx

The new valve Evolut FX has shown better commissural alignment vs. its predecessor Evolut Pro+. Prior studies have already shown commissure alignment facilitates post...

TRISCEND II: Transcatheter Replacement vs. Medical Treatment for Tricuspid Regurgitation

The EVOQUE device is designed with an intra-annular sealing system that provides excellent anatomical compatibility and an adaptable shape. It is currently available in...